[HTML][HTML] NF-ĸB axis in diabetic neuropathy, cardiomyopathy and nephropathy: A roadmap from molecular intervention to therapeutic strategies

A Rezaee, P Rahmanian, A Nemati, F Sohrabifard… - Heliyon, 2024 - cell.com
Diabetes mellitus (DM) is a metabolic illness defined by elevated blood glucose levels,
mediating various tissue alterations, including the dysfunction of vital organs. Diabetes …

Pro-inflammatory mechanisms in diabetic neuropathy: focus on the nuclear factor kappa B pathway

NE Cameron, MA Cotter - Current drug targets, 2008 - ingentaconnect.com
Neuropathy is a common complication of diabetes mellitus, which reduces the quality of life
and may be lifethreatening. The etiology is complex and multifactorial: hyperglycemia and …

[HTML][HTML] Diabetes induced renal complications by leukocyte activation of nuclear factor κ-B and its regulated genes expression

NM Darwish, YM Elnahas, FS AlQahtany - Saudi Journal of Biological …, 2021 - Elsevier
Type 2 diabetes mellitus (T2D) is a metabolic disorder characterized by inappropriate insulin
function. Despite wide progress in genome studies, defects in gene expression for diabetes …

[HTML][HTML] NF-κβ: a potential target in the management of vascular complications of diabetes

SV Suryavanshi, YA Kulkarni - Frontiers in pharmacology, 2017 - frontiersin.org
Diabetes is a metabolic disorder affecting large percentage of population worldwide. NF-κβ
plays key role in pathogenesis of vascular complications of diabetes. Persistent …

Plant compounds for the treatment of diabetes, a metabolic disorder: NF-κB as a therapeutic target

R Sahukari, J Punabaka, S Bhasha… - Current …, 2020 - ingentaconnect.com
Background: The prevalence of diabetes in the world population hás reached 8.8% and is
expected to rise to 10.4% by 2040. Hence, there is an urgent need for the discovery of drugs …

[HTML][HTML] Molecular mechanistic pathways targeted by natural compounds in the prevention and treatment of diabetic kidney disease

K Zhou, X Zi, J Song, Q Zhao, J Liu, H Bao, L Li - Molecules, 2022 - mdpi.com
Diabetic kidney disease (DKD) is one of the most common complications of diabetes, and its
prevalence is still growing rapidly. However, the efficient therapies for this kidney disease …

[HTML][HTML] The non-canonical NF-κB pathway and its contribution to β-cell failure in diabetes

K Meyerovich, F Ortis… - Journal of molecular …, 2018 - jme.bioscientifica.com
The prevalence of diabetes has reached 8.8% in worldwide population and is predicted to
increase up to 10.4% by 2040. Thus, there is an urgent need for the development of means …

Inflammation in diabetes complications: molecular mechanisms and therapeutic interventions

L Zhao, H Hu, L Zhang, Z Liu, Y Huang, Q Liu… - MedComm, 2024 - Wiley Online Library
At present, diabetes mellitus (DM) has been one of the most endangering healthy diseases.
Current therapies contain controlling high blood sugar, reducing risk factors like obesity …

[HTML][HTML] Peptide-based inhibition of IκB kinase/nuclear factor-κB pathway protects against diabetes-associated nephropathy and atherosclerosis in a mouse model of …

A Oguiza, C Recio, I Lazaro, B Mallavia, J Blanco… - Diabetologia, 2015 - Springer
Aims/hypothesis The canonical nuclear factor-κB (NF-κB) pathway mediated by the inhibitor
of NF-κB kinase (IKK) regulates the transcription of inflammatory genes involved in the …

Association of serum NF-κB levels with peripheral neuropathy in type 2 diabetes mellitus patients: a pilot study

N Priyadarsini, M Ramachandran… - … Molecular Biology and …, 2024 - degruyter.com
Objectives Hyperglycaemia-induced inflammation plays a vital role in the development of
diabetic peripheral neuropathy (DPN). Recent evidences had reported the involvement of …